Actavia Life Sciences, Inc. (RASP) Research

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

Market snapshot

Symbol
RASP
Price
$0.00
Day change
0.00%
Market cap
$385.9K
P/E ratio
-0.07x
52-week range
0.0004-0.004
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • ChitogenX Inc. (CHNXF)
  • Innovation Pharmaceuticals Inc. (IPIX)
  • Lift & Co. Corp. (LFCOF)
  • MedGen, Inc. (MDIN)
  • Nascent Biotech, Inc. (NBIO)
  • Paradigm Medical Industries, Inc. (PDMI)
  • RespireRx Pharmaceuticals Inc. (RSPI)
  • Tevano Systems Holdings Inc. (TEVNF)

Open Actavia Life Sciences, Inc. (RASP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.